These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 7556303

  • 21. Comparative Effectiveness of Ultrasonography, 99mTc-Sestamibi, and 18F-Fluorocholine PET/CT in Detecting Parathyroid Adenomas in Patients With Primary Hyperparathyroidism.
    Thanseer N, Bhadada SK, Sood A, Mittal BR, Behera A, Gorla AKR, Kalathoorakathu RR, Singh P, Dahiya D, Saikia UN, Rao SD.
    Clin Nucl Med; 2017 Dec; 42(12):e491-e497. PubMed ID: 28902729
    [Abstract] [Full Text] [Related]

  • 22. Technetium-99m-sestamibi single agent localization versus high resolution ultrasonography for the preoperative localization of parathyroid glands in patients with primary hyperparathyroidism.
    Billy HT, Rimkus DR, Hartzman S, Latimer RG.
    Am Surg; 1995 Oct; 61(10):882-8. PubMed ID: 7668462
    [Abstract] [Full Text] [Related]

  • 23. Parathyroid localization by computed tomographic scanning.
    Friedman M, Mafee MF, Shelton VK, Berlinger FG, Skolnik E.
    Arch Otolaryngol; 1983 Feb; 109(2):95-7. PubMed ID: 6849673
    [Abstract] [Full Text] [Related]

  • 24. Comparison of double-phase 99mTc-sestamibi with 123I-99mTc-sestamibi subtraction SPECT in hyperparathyroidism.
    Neumann DR, Esselstyn CB, Go RT, Wong CO, Rice TW, Obuchowski NA.
    AJR Am J Roentgenol; 1997 Dec; 169(6):1671-4. PubMed ID: 9393188
    [Abstract] [Full Text] [Related]

  • 25. [Is thallium scintigraphy of value in the preoperative localization of pathologic parathyroid glands?].
    Chapuis Y, Bonnichon P, Venot A, Place S, Pinto P, Zerbib M, Louvel A.
    J Chir (Paris); 1984 Dec; 121(12):709-13. PubMed ID: 6530408
    [Abstract] [Full Text] [Related]

  • 26. 18F-FDG PET rarely provides additional information to 11C-methionine PET imaging in hyperparathyroidism.
    Chicklore S, Schulte KM, Talat N, Hubbard JG, O'Doherty M, Cook GJ.
    Clin Nucl Med; 2014 Mar; 39(3):237-42. PubMed ID: 24445273
    [Abstract] [Full Text] [Related]

  • 27. A patient with classic severe primary hyperparathyroidism in whom both Tc-99m MIBI scintigraphy and FDG-PET failed to detect the parathyroid tumor.
    Seki K, Hashimoto K, Hisada T, Maeda M, Satoh T, Uehara Y, Matsumoto H, Oyama T, Yamada M, Mori M.
    Intern Med; 2004 Sep; 43(9):816-23. PubMed ID: 15497517
    [Abstract] [Full Text] [Related]

  • 28. Detection and localization of parathyroid adenomas in patients with hyperparathyroidism using a single radionuclide imaging procedure with technetium-99m-sestamibi (double-phase study).
    Taillefer R, Boucher Y, Potvin C, Lambert R.
    J Nucl Med; 1992 Oct; 33(10):1801-7. PubMed ID: 1328564
    [Abstract] [Full Text] [Related]

  • 29. [Detection and localization of parathyroid adenomas and hyperplasias in patients with hyperparathyroidism using thallium-201/technetium-99m parathyroid subtraction scintigraphy].
    Kanegae K, Itoh K, Kato C, Nagao K, Nakada K, Fujimori K, Furudate M.
    Kaku Igaku; 1994 May; 31(5):441-9. PubMed ID: 8028216
    [Abstract] [Full Text] [Related]

  • 30. Ultrasonography for preoperative localization of enlarged parathyroid glands in primary hyperparathyroidism: comparison with (99m)technetium sestamibi scintigraphy.
    Haber RS, Kim CK, Inabnet WB.
    Clin Endocrinol (Oxf); 2002 Aug; 57(2):241-9. PubMed ID: 12153604
    [Abstract] [Full Text] [Related]

  • 31. Localization of parathyroid adenoma by computed tomography.
    Ovenfors CO, Stark D, Moss A, Goldberg H, Clark O, Galante M.
    J Comput Assist Tomogr; 1982 Dec; 6(6):1094-8. PubMed ID: 7174925
    [Abstract] [Full Text] [Related]

  • 32. Comparison between 99mTc-tetrofosmin/pertechnetate subtraction scintigraphy and 99mTc-tetrofosmin SPECT for preoperative localization of parathyroid adenoma in an endemic goiter area.
    Gallowitsch HJ, Mikosch P, Kresnik E, Unterweger O, Lind P.
    Invest Radiol; 2000 Aug; 35(8):453-9. PubMed ID: 10946972
    [Abstract] [Full Text] [Related]

  • 33. The role of F18-fluorocholine positron emission tomography/magnetic resonance imaging in localizing parathyroid adenomas.
    Khafif A, Masalha M, Landsberg R, Domachevsky L, Bernstine H, Groshar D, Azoulay O, Lockman Y.
    Eur Arch Otorhinolaryngol; 2019 May; 276(5):1509-1516. PubMed ID: 30877424
    [Abstract] [Full Text] [Related]

  • 34. Preliminary experience with double-phase SPECT using Tc-99m sestamibi in patients with hyperparathyroidism.
    Neumann DR, Esselstyn CB, Kim EY, Go RT, Obuchowski NA, Rice TW.
    Clin Nucl Med; 1997 Apr; 22(4):217-21. PubMed ID: 9099475
    [Abstract] [Full Text] [Related]

  • 35. Radionuclide parathyroid imaging.
    O'Doherty MJ.
    J Nucl Med; 1997 Jun; 38(6):840-1. PubMed ID: 9189126
    [No Abstract] [Full Text] [Related]

  • 36. The usefulness of neck pinhole SPECT as a complementary tool to planar scintigraphy in primary and secondary hyperparathyroidism.
    Spanu A, Falchi A, Manca A, Marongiu P, Cossu A, Pisu N, Chessa F, Nuvoli S, Madeddu G.
    J Nucl Med; 2004 Jan; 45(1):40-8. PubMed ID: 14734671
    [Abstract] [Full Text] [Related]

  • 37. Dual isotope parathyroid imaging.
    Maslack MM, Brosbe RJ.
    Clin Nucl Med; 1986 Sep; 11(9):622-6. PubMed ID: 3021375
    [Abstract] [Full Text] [Related]

  • 38. Use of technetium Tc 99m sestamibi and iodine 123 radionuclide scan for preoperative localization of abnormal parathyroid glands in primary hyperparathyroidism.
    Halvorson DJ, Burke GJ, Mansberger AR, Wei JP.
    South Med J; 1994 Mar; 87(3):336-9. PubMed ID: 8134854
    [Abstract] [Full Text] [Related]

  • 39. Preoperative localization of parathyroid adenomas using thallium-technetium subtraction scintigraphy.
    Gordon L, Carr D.
    South Med J; 1986 Nov; 79(11):1337-8. PubMed ID: 3022393
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.